155 related articles for article (PubMed ID: 7854974)
1. Detection of somatostatin receptor subtype 2 (SSTR2) in established tumors and tumor cell lines: evidence for SSTR2 heterogeneity.
Taylor JE; Theveniau MA; Bashirzadeh R; Reisine T; Eden PA
Peptides; 1994; 15(7):1229-36. PubMed ID: 7854974
[TBL] [Abstract][Full Text] [Related]
2. Immunological detection of isoforms of the somatostatin receptor subtype, SSTR2.
Theveniau MA; Yasuda K; Bell GI; Reisine T
J Neurochem; 1994 Aug; 63(2):447-55. PubMed ID: 7518495
[TBL] [Abstract][Full Text] [Related]
3. SSTR2A is the dominant somatostatin receptor subtype expressed by inflammatory cells, is widely expressed and directly regulates T cell IFN-gamma release.
Elliott DE; Li J; Blum AM; Metwali A; Patel YC; Weinstock JV
Eur J Immunol; 1999 Aug; 29(8):2454-63. PubMed ID: 10458759
[TBL] [Abstract][Full Text] [Related]
4. Somatostatin receptor subtype gene expression in human and rodent tumors.
Eden PA; Taylor JE
Life Sci; 1993; 53(1):85-90. PubMed ID: 8515684
[TBL] [Abstract][Full Text] [Related]
5. Cloning and expression of a novel mouse somatostatin receptor (SSTR2B).
Vanetti M; Kouba M; Wang X; Vogt G; Höllt V
FEBS Lett; 1992 Oct; 311(3):290-4. PubMed ID: 1397330
[TBL] [Abstract][Full Text] [Related]
6. Gene expression of somatostatin receptor subtypes, SSTR1 and SSTR2, in human lung cancer cell lines.
Fujita T; Yamaji Y; Sato M; Murao K; Takahara J
Life Sci; 1994; 55(23):1797-806. PubMed ID: 7968260
[TBL] [Abstract][Full Text] [Related]
7. Identification of somatostatin receptor subtypes and an implication for the efficacy of somatostatin analogue SMS 201-995 in treatment of human endocrine tumors.
Kubota A; Yamada Y; Kagimoto S; Shimatsu A; Imamura M; Tsuda K; Imura H; Seino S; Seino Y
J Clin Invest; 1994 Mar; 93(3):1321-5. PubMed ID: 8132773
[TBL] [Abstract][Full Text] [Related]
8. Somatostatin receptor gene transfer inhibits established pancreatic cancer xenografts.
Celinski SA; Fisher WE; Amaya F; Wu YQ; Yao Q; Youker KA; Li M
J Surg Res; 2003 Nov; 115(1):41-7. PubMed ID: 14572771
[TBL] [Abstract][Full Text] [Related]
9. Applying HDACis to increase SSTR2 expression and radiolabeled DOTA-TATE uptake: from cells to mice.
Klomp MJ; van den Brink L; van Koetsveld PM; de Ridder CMA; Stuurman DC; Löwik CWGM; Hofland LJ; Dalm SU
Life Sci; 2023 Dec; 334():122173. PubMed ID: 37907154
[TBL] [Abstract][Full Text] [Related]
10. Cloned somatostatin receptors: identification of subtype-selective peptides and demonstration of high affinity binding of linear peptides.
Raynor K; Murphy WA; Coy DH; Taylor JE; Moreau JP; Yasuda K; Bell GI; Reisine T
Mol Pharmacol; 1993 Jun; 43(6):838-44. PubMed ID: 8100350
[TBL] [Abstract][Full Text] [Related]
11. Point mutation of the somatostatin receptor 2 gene in the human small cell lung cancer cell line COR-L103.
Zhang CY; Yokogoshi Y; Yoshimoto K; Fujinaka Y; Matsumoto K; Saito S
Biochem Biophys Res Commun; 1995 May; 210(3):805-15. PubMed ID: 7763254
[TBL] [Abstract][Full Text] [Related]
12. Somatostatin receptor subtype gene expression in pituitary adenomas.
Miller GM; Alexander JM; Bikkal HA; Katznelson L; Zervas NT; Klibanski A
J Clin Endocrinol Metab; 1995 Apr; 80(4):1386-92. PubMed ID: 7714115
[TBL] [Abstract][Full Text] [Related]
13. T lymphocytes isolated from the hepatic granulomas of schistosome-infected mice express somatostatin receptor subtype II (SSTR2) messenger RNA.
Elliott DE; Metwali A; Blum AM; Sandor M; Lynch R; Weinstock JV
J Immunol; 1994 Aug; 153(3):1180-6. PubMed ID: 7913111
[TBL] [Abstract][Full Text] [Related]
14. High affinity binding of [125I-Tyr11]somatostatin-14 to human small cell lung carcinoma (NCI-H69).
Taylor JE; Coy DH; Moreau JP
Life Sci; 1988; 43(5):421-7. PubMed ID: 2899828
[TBL] [Abstract][Full Text] [Related]
15. Stimulation of tyrosine phosphatase and inhibition of cell proliferation by somatostatin analogues: mediation by human somatostatin receptor subtypes SSTR1 and SSTR2.
Buscail L; Delesque N; Estève JP; Saint-Laurent N; Prats H; Clerc P; Robberecht P; Bell GI; Liebow C; Schally AV
Proc Natl Acad Sci U S A; 1994 Mar; 91(6):2315-9. PubMed ID: 7907795
[TBL] [Abstract][Full Text] [Related]
16. Expression of the SST receptor 2 in uveal melanoma is not a prognostic marker.
Kouch-el Filali M; Kilic E; Melis M; de Klein A; de Jong M; Luyten GP
Graefes Arch Clin Exp Ophthalmol; 2008 Nov; 246(11):1585-92. PubMed ID: 18682975
[TBL] [Abstract][Full Text] [Related]
17. Corticotropin-releasing factor receptors in human small cell lung carcinoma cells: radioligand binding, second messenger, and northern blot analysis data.
Dieterich KD; Grigoriadis DE; De Souza EB
Endocrinology; 1994 Oct; 135(4):1551-8. PubMed ID: 7925116
[TBL] [Abstract][Full Text] [Related]
18. Multiple gene transcripts of the somatostatin receptor SSTR2: tissue selective distribution and cAMP regulation.
Patel YC; Greenwood M; Kent G; Panetta R; Srikant CB
Biochem Biophys Res Commun; 1993 Apr; 192(1):288-94. PubMed ID: 8386508
[TBL] [Abstract][Full Text] [Related]
19. Splice variant of the somatostatin receptor 2 subtype, somatostatin receptor 2B, couples to adenylyl cyclase.
Reisine T; Kong H; Raynor K; Yano H; Takeda J; Yasuda K; Bell GI
Mol Pharmacol; 1993 Nov; 44(5):1016-20. PubMed ID: 7902529
[TBL] [Abstract][Full Text] [Related]
20. Somatostatin receptors in primary human breast cancer: quantitative analysis of mRNA for subtypes 1--5 and correlation with receptor protein expression and tumor pathology.
Kumar U; Grigorakis SI; Watt HL; Sasi R; Snell L; Watson P; Chaudhari S
Breast Cancer Res Treat; 2005 Jul; 92(2):175-86. PubMed ID: 15986128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
